Adeno-associated viral vectors and the retina

Advances in Experimental Medicine and Biology

Volumn 613, Issue , 2008, Pages 121-128

  Alexander, John J ^a   Hauswirth, William W ^b  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

PARVOVIRUS VECTOR; PROTEIN; RPE65 PROTEIN; UNCLASSIFIED DRUG; VIRUS DNA; VIRUS PROTEIN;

CELL TYPE; CLINICAL TRIAL; CONFERENCE PAPER; DNA REPLICATION; ENHANCER REGION; GENE EXPRESSION; GENETIC TRANSDUCTION; HUMAN; IMMEDIATE EARLY GENE; LEBER CONGENITAL AMAUROSIS; NONHUMAN; PHOTORECEPTOR; PIGMENT CELL; PRIORITY JOURNAL; PROMOTER REGION; RETINA; RETINA DEGENERATION; RETINOSCHISIS; TRANSGENE; VIRAL GENE DELIVERY SYSTEM; VIRAL GENE THERAPY; VIRUS RECOMBINANT; VIRUS REPLICATION; ADENO ASSOCIATED VIRUS; ANIMAL; GENE THERAPY; GENE TRANSFER; GENE VECTOR; GENETICS; METABOLISM; RETINA DISEASE; REVIEW;

ANIMALS; DEPENDOVIRUS; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HUMANS; RETINA; RETINAL DISEASES;

EID: 38949183082     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-0-387-74904-4_13     Document Type: Conference Paper

References (31)

1. Acland, G.M., Aguirre, G.D., Bennett, J., Aleman, T.S., Cideciyan, A.V., Bennicelli, J. et al. 2005, Long-term restoration of rod and cone vision by single dose rAAV-mediated gene transfer to the retina in a canine model of childhood blindness. Mol. Ther. 12: 1072-1082.
2. Acland, G.M., Aguirre, G.D., Ray, J., Zhang, Q., Aleman, T.S., Cideciyan, A.V. et al. 2001, Gene therapy restores vision in a canine model of childhood blindness. Nat. Genet. 28: 92-95.
3. Atchison, R.W., Casto, B.C., and Hammon, W.M. 1965, Adenovirus-associated defective virus particles. Science 149: 754-756.
4. Auricchio, A., Kobinger, G., Anand, V., Hildinger, M., O 'Connor, E., Maguire, A.M. et al. 2001, Exchange of surface proteins impacts on viral vector cellular specificity and transduction characteristics: the retina as a model. Hum. Mol. Genet. 10: 3075-3081.
5. Bantel-Schaal, U. and zur Hausen, H. 1984, Characterization of the DNA of a defective human parvovirus isolated from a genital site. Virology 134: 52-63.
6. Berns, K.I. and Giraud, C. 1996, Biology of adeno-associated virus. Curr. Top. Microbiol. Immunol. 218: 1-23.
7. Boulanger, A., Liu, S., Henningsgaard, A.A., Yu,S., and Redmond, T.M. 2000, The upstream region of the Rpe65 gene confers retinal pigment epithelium-specific expression in vivo and in vitro and contains critical octamer and E-box binding sites. J. Biol. Chem. 275: 31274-31282.
8. Caspi, R.R. 2006, Ocular autoimmunity: the price of privilege? Immunol. Rev. 213: 23-35.
9. Choi, V.W., McCarty, D.M., and Samulski, R.J. 2005, AAV hybrid serotypes: improved vectors for gene delivery. Curr. Gene Ther. 5: 299-310.
10. Deng, W.T., Yan, Z., Dinculescu, A., Pang, J., Teusner, J.T., Cortez, N.G. et al. 2005, Adenoassociated virus-mediated expression of vascular endothelial growth factor peptides inhibits retinal neovascularization in a mouse model of oxygen-induced retinopathy. Hum. Gene Ther. 16: 1247-1254.
11. Dinculescu, A., Glushakova, L., Min, S.H., and Hauswirth, W.W. 2005, Adeno-associated virusvectored gene therapy for retinal disease. Hum. Gene Ther. 16: 649-663.
12. Esumi, N., Oshima, Y., Li,Y., Campochiaro, P.A., and Zack, D.J. 2004, Analysis of the VMD2 promoter and implication of E-box binding factors in its regulation. J. Biol. Chem. 279:19064-19073.
13. Flannery, J.G., Zolotukhin, S., Vaquero, M.I., LaVail, M.M., Muzyczka, N., and Hauswirth, W.W. 1997, Efficient photoreceptor-targeted gene expression in vivo by recombinant adenoassociated virus. Proc. Natl. Acad. Sci. U. S. A. 94: 6916-6921.
14. Glushakova, L.G., Timmers, A.M., Pang, J., Teusner, J.T., and Hauswirth, W.W. 2006, Human blue-opsin promoter preferentially targets reporter gene expression to rat s-cone photoreceptors. Invest Ophthalmol. Vis. Sci. 47: 3505-3513.
15. Gorbatyuk, M., Justilien, V., Liu, J., Hauswirth, W.W., and Lewin, A.S. 2007, Preservation of photoreceptor morphology and function in P23H rats using an allele independent ribozyme. Exp. Eye Res. 84: 44-52.
16. Gu, S.M., Thompson, D.A., Srikumari, C.R., Lorenz, B., Finckh, U., Nicoletti, A. et al. 1997, Mutations in RPE65 cause autosomal recessive childhood-onset severe retinal dystrophy. Nat. Genet. 17: 194-197.
17. Guy, J., Qi,X., Muzyczka, N., and Hauswirth, W.W. 1999, Reporter expression persists 1 year after adeno-associated virus-mediated gene transfer to the optic nerve. Arch. Ophthalmol. 117:929-937.
18. Hauswirth, W.W. and Berns, K.I. 1977, Origin and termination of adeno-associated virus DNA replication. Virology 78: 488-499.
19. Hermonat, P.L. and Muzyczka, N. 1984, Use of adeno-associated virus as a mammalian DNA cloning vector: transduction of neomycin resistance into mammalian tissue culture cells. Proc. Natl. Acad. Sci. U. S. A. 81: 6466-6470.
20. Huttner, N.A., Girod, A., Perabo, L., Edbauer, D., Kleinschmidt, J.A., Buning, H., and Hallek, M. 2003, Genetic modifications of the adeno-associated virus type 2 capsid reduce the affinity and the neutralizing effects of human serum antibodies. Gene Ther. 10: 2139-2147.
21. Jacobson, S.G., Acland, G.M., Aguirre, G.D., Aleman, T.S., Schwartz, S.B., Cideciyan, A.V. et al. 2006a, Safety of recombinant adeno-associated virus type 2-RPE65 vector delivered by ocular subretinal injection. Mol. Ther. 13: 1074-1084.
22. Jacobson, S.G., Boye, S.L., Aleman, T.S., Conlon, T.J., Zeiss, C.J., Roman, A.J. et al. 2006b, Safety in nonhuman primates of ocular AAV2-RPE65, a candidate treatment for blindness in Leber congenital amaurosis. Hum. Gene Ther. 17: 845-858.
23. Kiang, A.S., Palfi, A., Ader, M., Kenna, P.F., Millington-Ward, S., Clark, G. et al. 2005, Toward a gene therapy for dominant disease: validation of an RNA interference-based mutationindependent approach. Mol. Ther. 12: 555-561.
24. Marlhens, F., Bareil, C., Griffoin, J.M., Zrenner, E., Amalric, P., Eliaou, C. et al. 1997, Mutations in RPE65 cause Leber 's congenital amaurosis. Nat. Genet. 17: 139-141.
25. McCarty, D.M., Young, S.M., Jr., and Samulski, R.J. 2004, Integration of adeno-associated virus (AAV) and recombinant AAV vectors. Annu. Rev. Genet. 38: 819-845.
26. Min, S.H., Molday, L.L., Seeliger, M.W., Dinculescu, A., Timmers, A.M., Janssen, A. et al. 2005, Prolonged recovery of retinal structure/function after gene therapy in an Rs1h-deficient mouse model of x-linked juvenile retinoschisis. Mol. Ther. 12: 644-651.
27. Muzyczka, N. and Berns, K.I. 2001, Chapter 69, Fields Virology . Lippincott Williams & Wilkins. Rolling, F. 2004, Recombinant AAV-mediated gene transfer to the retina: gene therapy perspectives. Gene Ther. 11 Suppl 1: S26-S32.
28. Sun, H., Tsunenari, T., Yau, K.W., and Nathans, J. 2002, The vitelliform macular dystrophy protein defines a new family of chloride channels. Proc. Natl. Acad. Sci. U. S. A . 99: 4008-4013.
29. Warrington, K.H., Jr. and Herzog, R.W. 2006, Treatment of human disease by adeno-associated viral gene transfer. Hum. Genet. 119: 571-603.
30. Wu, Z., Asokan, A., and Samulski, R.J. 2006, Adeno-associated virus serotypes: vector toolkit for human gene therapy. Mol. Ther. 14: 316-327.
31. Yue, Y. and Duan, D. 2003, Double strand interaction is the predominant pathway for intermolecular recombination of adeno-associated viral genomes. Virology 313: 1-7.